The safety of omalizumab therapy in a patient with severe persistent allergic asthma and hepatitis C.

Antonicelli, Leonardo; Stagnozzi, Giorgia; Giuliodoro, Simona; Abbruzzetti, Alessandra; Massaccesi, Chiara

Antonicelli, Leonardo; Stagnozzi, Giorgia; Giuliodoro, Simona; Abbruzzetti, Alessandra; Massaccesi, Chiara.

Ann Allergy Asthma Immunol ; 103(3): 269-70, 2009 Sep.

Article in En | MEDLINE | ID: mdl-19788028

Subject(s)

Anti-Asthmatic Agents/administration & dosage; Antibodies, Monoclonal/administration & dosage; Asthma/diagnosis; Hepacivirus/immunology; Hepatitis C/diagnosis; Immunotherapy; Lung/enzymology; Adrenal Cortex Hormones/administration & dosage; Adrenergic beta-Agonists/administration & dosage; Airway Obstruction; Anti-Asthmatic Agents/adverse effects; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal, Humanized; Antiviral Agents/administration & dosage; Asthma/complications; Asthma/physiopathology; Hepacivirus/growth & development; Hepacivirus/physiology; Hepatitis C/complications; Hepatitis C/physiopathology; Humans; Interferon-alpha/administration & dosage; Lung/pathology; Lung/virology; Male; Middle Aged; Omalizumab; Respiratory Function Tests; Viral Load; Virulence

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Asthma / Hepatitis C / Hepacivirus / Anti-Asthmatic Agents / Immunotherapy / Lung / Antibodies, Monoclonal Limits: Humans / Male / Middle aged Language: En Year: 2009 Type: Article

Fulltext

XML

PubMed Links

Search on Google